Cel Sci Corporation (CVM)

[Biobonic]

Sidelines at current. Do see it as a decent trading vehicle, just I'm not good at that.

From my perspective, which is not medically trained or schooled, what Multikine does is far superior to the 2nd line and 3rd line treatments. That said, when people are facing the end, any meds that can grant more days amongst the living can ask a very high price.

Some meds have an administer schedule of 400 mg every six weeks. (Think Keytruda) How much money does that bring in!!

Multikine got one 3 week shot, and in spite of the radiotherapy benefit, the improvement for those who also had Multikine is astounding.

Question to ask is, how did Keytruda get so many indications so quickly?

Merck bet the farm on Keytruda when they realized what it could do.
Forbes has a good article on the history: The Startling History Behind Merck's New Cancer Blockbuster.

Cel Sci didn't have the money to do what Merck did.

Will someone pick this up? IMO, someone should - it's proven.